Literature DB >> 22382406

Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia.

Simone Guadagna1, Margaret M Esiri, Robert J Williams, Paul T Francis.   

Abstract

Agitation and aggressive behavior are common symptoms of Alzheimer's disease (AD), and tangle density in frontal cortex is a possible regional substrate of these behaviors. To investigate this further, 16 AD patients, 8 patients with non-AD dementia, and 13 age-matched control subjects for frontal cortex and, respectively, 21, 7, and 6 patients for parietal cortex were analyzed for tau and phospho-tau by enzyme-linked immunosorbent assay (ELISA). Agitation/aggression was determined by the Present Behavioural Examination. In a subset of cases, glycogen synthase kinase-3β (GSK-3β) phosphorylation and protein phosphatase 2A (PP2A) expression were measured. Phospho-tau and the phospho-tau/total tau ratio were elevated in AD in both cortical regions. In keeping with our hypothesis, the phospho-tau/total tau ratio was elevated in the frontal cortex of those patients with agitation/aggression during life, and there was a significant correlation (p = 0.024) between these behaviors and the phospho-tau/total tau ratio in the cortex. PP2A expression was lower (p < 0.01) in the frontal cortex of patients with high tau phosphorylation. This study confirms a link between tau phosphorylation and agitation/aggression and suggests that reducing tau phosphorylation may provide symptomatic relief.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22382406     DOI: 10.1016/j.neurobiolaging.2012.01.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  13 in total

Review 1.  Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.

Authors:  Celina S Liu; Sarah A Chau; Myuri Ruthirakuhan; Krista L Lanctôt; Nathan Herrmann
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 2.  Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?

Authors:  Paul B Rosenberg; Milap A Nowrangi; Constantine G Lyketsos
Journal:  Mol Aspects Med       Date:  2015-06-03

3.  Xanthoceraside attenuates tau hyperphosphorylation and cognitive deficits in intracerebroventricular-streptozotocin injected rats.

Authors:  Peng Liu; Li-Bo Zou; Li-Hua Wang; Qing Jiao; Tian-Yan Chi; Xue-Fei Ji; Ge Jin
Journal:  Psychopharmacology (Berl)       Date:  2014-01       Impact factor: 4.530

4.  Tau hyperphosphorylation is associated with spatial learning and memory after exposure to benzo[a]pyrene in SD rats.

Authors:  Jisheng Nie; Lei Duan; Zhiwei Yan; Qiao Niu
Journal:  Neurotox Res       Date:  2013-03-19       Impact factor: 3.911

5.  Neonatal DNA methylation and early-onset conduct problems: A genome-wide, prospective study.

Authors:  Charlotte A M Cecil; Esther Walton; Sara R Jaffee; Tom O'Connor; Barbara Maughan; Caroline L Relton; Rebecca G Smith; Wendy McArdle; Tom R Gaunt; Isabelle Ouellet-Morin; Edward D Barker
Journal:  Dev Psychopathol       Date:  2017-06-09

Review 6.  Behavioral and psychological symptoms in Alzheimer's disease.

Authors:  Xiao-Ling Li; Nan Hu; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Biomed Res Int       Date:  2014-07-15       Impact factor: 3.411

7.  Factors affecting directional migration of bone marrow mesenchymal stem cells to the injured spinal cord.

Authors:  Peng Xia; Su Pan; Jieping Cheng; Maoguang Yang; Zhiping Qi; Tingting Hou; Xiaoyu Yang
Journal:  Neural Regen Res       Date:  2014-09-15       Impact factor: 5.135

8.  Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.

Authors:  Cyril Bories; Dany Arsenault; Myriam Lemire; Cyntia Tremblay; Yves De Koninck; Frédéric Calon
Journal:  Aging (Albany NY)       Date:  2017-05-16       Impact factor: 5.682

9.  Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients.

Authors:  Jasinda H Lee; Shu Qing Koh; Simone Guadagna; Paul T Francis; Margaret M Esiri; Christopher P Chen; Peter T-H Wong; Gavin S Dawe; Mitchell K P Lai
Journal:  Psychopharmacology (Berl)       Date:  2015-11-06       Impact factor: 4.530

Review 10.  Circadian Rhythm and Alzheimer's Disease.

Authors:  Jan Homolak; Monika Mudrovčić; Barbara Vukić; Karlo Toljan
Journal:  Med Sci (Basel)       Date:  2018-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.